Showing results (11-20 of 174) with videos related to
Sort By:
Pageof 18
Life Sciences|January 1, 1990
An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidasesM A Hussain, C A Koval, A B Shenvi, et al.Journal of Pharmaceutical Sciences|December 1, 1990
Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehiclesB J Aungst, J A Blake, N J Rogers, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1990
Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivativeM A Hussain, S M Rowe, A B Shenvi, et al.Journal of Pharmaceutical Sciences|January 1, 1995
Nasal mucosal metabolism and absorption of pentapeptide enkephalin analogs having varying N-terminal amino acidsM A Hussain, R Seetharam, R R Wilk, et al.Journal of Pharmaceutical Sciences|October 1, 1993
Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolismB J AungstPharmaceutical Research|March 1, 1989
Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritantsB J AungstPharmaceutical Research|January 1, 1996
Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonistB J Aungst, H SaitohPharmaceutical Research|September 1, 1995
Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestineH Saitoh, B J AungstPharmaceutical Research|August 1, 1997
Prodrug and analog approaches to improving the intestinal absorption of a cyclic peptide, GPIIb/IIIa receptor antagonistH Saitoh, B J AungstPageof 18